» Authors » Lacey G Campbell

Lacey G Campbell

Explore the profile of Lacey G Campbell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 90
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez F, Campbell L, Liu W, Shipley J, Itohara S, Patterson G, et al.
Am J Transplant . 2005 Mar; 5(4 Pt 1):671-83. PMID: 15760390
This study was designed to define the roles of matrix metalloproteinase (MMP)-2 and MMP-9 in obliterative airway disease (OAD) in heterotopic murine tracheal allografts, considered a suitable animal model for...
2.
Campbell L, Ramachandran S, Liu W, Shipley J, Itohara S, Rogers J, et al.
Am J Transplant . 2005 Feb; 5(3):517-28. PMID: 15707406
Recent studies have shown an increased expression of several matrix metalloproteinases (MMP) during cardiac, renal and pulmonary allograft rejection. To further define the roles of MMP-2 and MMP-9 in the...
3.
Jaramillo A, Narayanan K, Campbell L, Benshoff N, Lybarger L, Hansen T, et al.
Breast Cancer Res Treat . 2004 Nov; 88(1):29-41. PMID: 15538043
A breast cancer-associated antigen, mammaglobin-A, is specifically expressed in 80% of primary breast tumors. The definition of immune responses against this highly expressed breast cancer-specific antigen should be of great...
4.
Narayanan K, Jaramillo A, Benshoff N, Campbell L, Fleming T, Dietz J, et al.
J Natl Cancer Inst . 2004 Sep; 96(18):1388-96. PMID: 15367572
Background: A novel breast cancer-associated antigen, mammaglobin-A, is expressed in 80% of primary breast tumors. The characterization of immune responses against this highly expressed breast cancer-specific antigen would be of...
5.
Manna P, Jaramillo A, Majumder K, Campbell L, Fleming T, Dietz J, et al.
Breast Cancer Res Treat . 2003 Jun; 79(1):133-6. PMID: 12779090
Mammaglobin-A is exclusively expressed by breast cancer cells. Thus, mammaglobin-A-specific T cell immune responses may be useful for the design of new breast cancer-specific immunotherapies. We show herein that CD8+...